表紙
市場調查報告書
商品編碼
1078440

中東、非洲的體外診斷用藥(IVD)市場

In Vitro Diagnostics (IVD) in Middle East and Africa

出版日期: | 出版商: Kalorama Information | 英文 102 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

在中東和非洲,由於國民收入增加,生活水準提高。因此,心臟病(高血壓,高膽固醇,高血糖)的發生率變高。實際上,中東、非洲地區是高心臟病發生率的地區之一,住院的人增加。因此,診斷用檢驗設備和醫療設備的需求增加。

本報告提供中東、非洲的體外診斷用藥(IVD)市場相關調查,市場概要,以及主要疾病,各國的趨勢,及地區市場整體趨勢等資訊。

目錄

第1章 摘要整理

第2章 中東和非洲:地區概要

  • 概要
  • 地區市場概要
  • 人口
  • 影響中東/非洲人口的主要疾病
  • 心血管疾病
  • 癌症
  • 糖尿病
  • 中東呼吸系統症候群(MERS)
  • MERS情形的最新趨勢
  • 對MERS的市場反應
  • SARS-CoV-2(COVID-19)
  • 中東、非洲的COVID-19狀況
  • 對COVID-19的市場反應

第3章 埃及IVD市場

第4章 伊朗的IVD市場

第5章 伊拉克的IVD市場

第6章 以色列的IVD市場

第7章 約旦的IVD市場

第8章 沙烏地阿拉伯的IVD市場

第12章 中東、非洲的IVD市場全體

  • 概要
  • 概要
  • 臨床化學市場
  • 免疫檢測市場
  • 微生物學市場
  • 照護現場市場
  • 組織學市場
目錄
Product Code: 22-034

There has been an increasing standard of living in the Middle East and Africa due to higher national income. This has contributed to a higher incidence of heart disease - high blood pressure, high cholesterol and high blood sugar. In fact, the Middle East/Africa region is one of the higher areas for heart disease which has prompted more individuals being admitted to the hospital. This has caused an uptick in the demand for diagnostic testing devices and medical devices.

This report provides an overview of developments in the in vitro diagnostics industry in the Middle East and Africa.

The countries covered are:

  • Egypt
  • Iran
  • Iraq
  • Israel
  • Jordan
  • Saudi Arabia
  • South Africa
  • Turkey
  • United Arab Emirates (UAE)
  • Other Mideast (Bahrain, Cyprus, Gaza Strip, Kuwait, Lebanon, Oman, Qatar, Syria, West Bank, Yemen)
  • Other Africa (Algeria, Congo, Sudan, Libya, Chad, Niger, Angola, Mali, Ethiopia, etc.)

Scope

The Middle East, Africa market for in vitro diagnostics is provided in U.S. dollars for the years 2021 - 2026.

The report covers six segments of the IVD market in the Middle East:

  • Clinical Chemistry
  • Immunoassay
  • Microbiology
  • Point of Care (POC)
  • Histology - traditional stains
  • Other (includes nucleic acid assays, blood bank ABO, sequencing, prenatal tests and other areas not covered specifically in the above segments)

Table of Contents

Chapter 1: Executive Summary

  • Overview
  • Scope and Methodology
  • Size and Growth of the Market
    • Figure 1-1: IVD in the Middle East, Africa, 2021-2026 CAGR 2.2% ($ millions)

Chapter 2: Middle East and Africa: Regional Overview

  • Overview
  • Regional Market Overview
    • Table 2-1: Mideast/Africa In Vitro Diagnostic Sales by Country, 2021-2026 ($ millions) (Egypt, Iran, Iraq, Israel, Jordan, Saudi Arabia, Turkey, United Arab Emirates, Other Mideast, South Africa, Other Africa, Total)
    • Figure 2-1: Mideast/Africa In Vitro Diagnostic Sales by Country, 2021-2026 - Eight Countries Generate nearly 75% Market Value (Egypt, Iran, Iraq, Israel, Jordan, Saudi Arabia, Turkey, United Arab Emirates, Other Mideast, South Africa, Other Africa)
  • Population
    • Table 2-2: Elderly Dependency Ratio in Middle East and Other Select Countries, 2010 and 2050
    • Table 2-3: World Population: Major Countries in the Mideast and Africa Region (Egypt, Iraq, Iran, Israel, Jordan, Saudi Arabia, South Africa, Turkey, United Arab Emirates), 2010-2030 (million persons)
    • Figure 2-2: Middle East and Africa Region, Population Density by Country, 2022 Est.
  • Major Diseases Affecting the Middle Eastern / African Population
  • Cardiovascular Diseases
  • Cancer
    • Table: 2-4: The Most Frequent Cancers by Country of Middle East and Africa (%) As Reported by National Cancer Registry Programs, 2020
  • Diabetes
    • Table 2-5: People Living with Diabetes in Middle East/Africa Region and Projections 2045 (millions of people)
  • Middle Eastern Respiratory Syndrome (MERS)
  • MERS Situation Update, February 2022
    • Table 2-6: Epidemiological Characteristics of MERS Cases Reported Globally, (Dec 2017 - May 2018 through Sept 2021 - Feb 2022)
  • Market Response to MERS
  • SARS-CoV-2 (COVID-19)
  • COVID-19 Situation in MEA
  • Market Response to COVID-19
    • Table 2-7: Selected MEA COVID-19 Statistics - Total Cases, Total Deaths, New Cases Last 7 Days, May 20, 2022
    • Figure 2-3: Selected MEA COVID-19 Statistics - Total Cases, Total Deaths, New Cases Last 7 Days , May 20, 2022

Chapter 3: Egypt IVD Market

  • Overview
  • Market Summary
    • Table 3-1: Egypt In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
    • Figure 3-1: Egypt In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
    • Table 3-2: Egypt - POC Market Distribution, 2021-2026 (%) (POC Glucose, POC Other)
    • Figure 3-2: POC Market Distribution (POC Glucose, POC Other) for Egypt, 2021 and 2026
  • Market Strengths and Weaknesses (Drivers and Inhibitors)
    • Figure 3-3: Egypt IVD Market: Strengths and Weaknesses
  • COVID-19 Pandemic Situation
    • Table 3-3: COVID-19 Pandemic Situation: Egypt, updated May 20, 2022
    • Figure 3-4: COVID-19 Pandemic Confirmed Case Pattern, through May 20, 2022
  • Market Participant Activity
    • Figure 3-5: Selected IVD-Related Participant Activity: Egypt

Chapter 4: Iran IVD Market

  • Overview
    • Figure 4-1: Iran's Crude Oil Production, 1975 - 2020 (millions of barrels per day)
  • Market Summary
    • Table 4-1: Iran In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
    • Figure 4-2: Iran In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
    • Table 4-2: Iran - POC Market Distribution, 2021-2026 (%) (POC Glucose, POC Other)
    • Figure 4-3: POC Market Distribution (POC Glucose, POC Other) for Iran, 2021 and 2026
  • Market Strengths and Weaknesses (Drivers and Inhibitors)
    • Figure 4-4: Iran IVD Market: Strengths and Weaknesses
  • COVID-19 Pandemic Situation
    • Table 4-3: COVID-19 Pandemic Situation: Iran, updated May 20, 2022
    • Figure 4-5: COVID-19 Pandemic Confirmed Case Pattern, through May 20, 2022

Chapter 5: Iraq IVD Market

  • Overview
    • Figure 5-1: Iraq's Production and Consumption of Petroleum and Other Liquids, 1990 - 2020 (millions of barrels per day)
  • Market Summary
    • Table 5-1: Iraq In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
    • Figure 5-2: Iraq In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
    • Table 5-2: Iraq - POC Market Distribution, 2021-2026 (%) (POC Glucose, POC Other)
    • Figure 5-3: POC Market Distribution (POC Glucose, POC Other) Percent for 2021 and 2026
  • Market Strengths and Weaknesses (Drivers and Inhibitors)
    • Figure 5-4: Iraq IVD Market: Strengths and Weaknesses
  • COVID-19 Pandemic Situation
    • Table 5-3: COVID-19 Pandemic Situation: Iraq, updated May 20, 2022
    • Figure 5-5: COVID-19 Pandemic Confirmed Case Pattern, through May 20, 2022
  • Market Participant Activity
    • Figure 5-6: Selected IVD-Related Participant Activity: Iraq

Chapter 6: Israel IVD Market

  • Overview
  • Market Summary
    • Table 6-1: Israel In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
    • Figure 6-1: Israel In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
    • Table 6-2: Israel - POC Market Distribution, 2021-2026 (%) (POC Glucose, POC Other)
    • Figure 6-2: POC Market Distribution (POC Glucose, POC Other) for Israel, 2021 and 2026
  • Market Strengths and Weaknesses (Drivers and Inhibitors)
    • Figure 6-3: Israel IVD Market: Strengths and Weaknesses
  • COVID-19 Pandemic Situation
    • Table 6-3: COVID-19 Pandemic Situation: Israel, updated May 20, 2022
    • Figure 6-4: COVID-19 Pandemic Confirmed Case Pattern, through May 20, 2022
  • Market Participant Activity
    • Figure 6-5: Selected IVD-Related Participant Activity: Israel

Chapter 7: Jordan IVD Market

  • Overview
  • Market Summary
    • Table 7-1: Jordan In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
    • Figure 7-1: Jordan In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
    • Table 7-2: Jordan - POC Market Distribution, 2021-2026 (%) (POC Glucose, POC Other)
    • Figure 7-2: POC Market Distribution (POC Glucose, POC Other) for Jordan, 2021 and 2026
  • Market Strengths and Weaknesses (Drivers and Inhibitors)
    • Figure 7-3: Jordan IVD Market: Strengths and Weaknesses
  • COVID-19 Pandemic Situation
    • Table 7-3: COVID-19 Pandemic Situation: Jordan, updated May 20, 2022
    • Figure 7-4: COVID-19 Pandemic Confirmed Case Pattern, through May 15, 2022

Chapter 8: Saudi Arabia IVD Market

  • Overview
    • Figure 8-1: Saudi Arabia Crude Oil Production, Annual Average Per Day (millions of barrels), 1995-2020
  • Market Summary
    • Table 8-1: Saudi Arabia In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
    • Figure 8-2: Saudi Arabia In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
    • Table 8-2: Saudi Arabia - POC Market Distribution, 2021-2026 (%) (POC Glucose, POC Other)
    • Figure 8-3: POC Market Distribution (POC Glucose, POC Other) for Saudi Arabia, 2021 and 2026
  • Market Strengths and Weaknesses (Drivers and Inhibitors)
    • Figure 8-4: Saudi Arabia IVD Market: Strengths and Weaknesses
  • COVID-19 Pandemic Situation
    • Table 8-3: COVID-19 Pandemic Situation: Saudi Arabia, updated May 20, 2022
    • Figure 8-5: COVID-19 Pandemic Confirmed Case Pattern, through May 20, 2022
  • Market Participant Activity
    • Figure 8-6: Selected IVD-Related Participant Activity: Saudi Arabia

Chapter 9: South Africa IVD Market

  • Overview
  • Market Summary
    • Table 9-1: South Africa In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
    • Figure 9-1: South Africa In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
    • Table 9-2: South Africa - POC Market Distribution, 2021-2026 (%) (POC Glucose, POC Other)
    • Figure 9-2: POC Market Distribution (POC Glucose, POC Other) for South Africa, 2021 and 2026
  • Market Strengths and Weaknesses (Drivers and Inhibitors)
    • Figure 9-3: South Africa IVD Market: Strengths and Weaknesses
  • Ebola Outbreaks
    • Figure 9-4: DRC Ebola Virus Disease Outbreak: Equateur Province, 2022 (Provinces and Health Zones)
    • Table 9-3: Ebola Virus Outbreaks by Species and Size, 1976 - 2021
  • COVID-19 Pandemic Situation
    • Table 9-4: COVID-19 Pandemic Situation: South Africa, updated May 20, 2022
    • Figure 9-5: COVID-19 Pandemic Confirmed Case Pattern, through May 20, 2022
  • Market Participant Activity
    • Figure 9-6: Selected IVD-Related Participant Activity: South Africa

Chapter 10: Turkey IVD Market

  • Overview
  • Market Summary
    • Table 10-1: Turkey In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
    • Figure 10-1: Turkey In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
    • Table 10-2: Turkey - POC Market Distribution, 2021-2026 (%) (POC Glucose, POC Other)
    • Figure 10-2: POC Market Distribution (POC Glucose, POC Other) for Turkey, 2021 and 2026
  • Market Strengths and Weaknesses (Drivers and Inhibitors)
    • Figure 10-3: Turkey IVD Market: Strengths and Weaknesses
  • COVID-19 Pandemic Situation
    • Table 10-3: COVID-19 Pandemic Situation: Turkey, updated May 20, 2022
    • Figure10-4: COVID-19 Pandemic Confirmed Case Pattern, through May 20, 2022
  • Market Participant Activity
    • Figure 10-5: Selected IVD-Related Participant Activity: Turkey

Chapter 11: United Arab Emirates (UAE) IVD Market

  • Overview
    • Figure 11-1: UAE's Production and Consumption of Petroleum and Other Liquids, 2008-2018 (millions of barrels per day)
  • Market Summary
    • Table 11-1: United Arab Emirates In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
    • Figure 11-2: United Arab Emirates In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
    • Table 11-2: United Arab Emirates - POC Market Distribution, 2021-2026 (%) (POC Glucose, POC Other)
    • Figure 11-:3 POC Market Distribution (POC Glucose, POC Other) for United Arab Emirates, 2021 and 2026
  • Market Strengths and Weaknesses (Drivers and Inhibitors)
    • Figure 11-4: United Arab Emirates IVD Market: Strengths and Weaknesses
  • COVID-19 Pandemic Situation
    • Table 11-3: COVID-19 Pandemic Situation: United Arab Emirates, updated May 20, 2022
    • Figure 11-5: COVID-19 Pandemic Confirmed Case Pattern, through May 20, 2022
  • Market Participant Activity
    • Figure 11-6: Selected IVD-Related Participant Activity: United Arab Emirates

Chapter 12: Total Mideast & Africa IVD Market

  • Overview
  • Summary
    • Table 12-1: Mideast/Africa In Vitro Diagnostic Sales by Market Segment, 2021-2026 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
  • Clinical Chemistry Market
  • Immunoassay Market
  • Microbiology Market
  • Point-of-Care Market
  • Histology Market